ArticleFrontiers in pharmacology2021

BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor.

Jiaxing Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.